ITGA8 and neoplasm: Combined with our results, we speculated that interference against ITGA8 expression could effectively increase the infiltration of CD8+ T cells in SKCM TIME and reduce the percentage of tumor cells in SKCM, which is a potential target of SKCM targeted therapy (Figure 7).